BioLineRx Statistics
NASDAQ: BLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.9639-0.0861 (-8.20%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioLineRx by the numbers
BioLineRx has a market capitalization of $4.8 million based on 4.98M shares outstanding. With trailing EPS of $0.00, BioLineRx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 52.3% below its 50-day average and 63.3% below its 200-day average.
Average daily trading volume is 23.43K shares, or about $22,580 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BLRX valuation vs. peer median
| Metric | BLRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.80M | $4.89M | -2% |
| Avg. volume | 23.43K | 166.64K | -86% |
Peer median across 8 companies: PULM, SNGX, PCSA, CANF, CNSP, UPC, TOVX, SCNX.
Valuation
- Market cap
- $4.80M
- Price / sales (latest FY)
- 4.07
- EPS (TTM)
- $0.00
- Shares outstanding
- 4.98M
Price and trading
- Previous close
- 1.05
- Open
- 1.10
- Day range
- 0.78 – 1.10
- 52-week range
- 0.78 – 3.95
- 52-week change
- -70.34%
- Beta
- —
- Volume
- 38.77K
- Average volume
- 23.43K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 23, 2026
Additional statistics
- Market Cap
- 4.80M
- Forward Pe
- -0.38
- Eps
- 0.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.95
- Week52 Low
- 0.78
- Avg Volume
- 23,426.00
- Shares Outstanding
- 4.98M
- Ma50
- 2.02
- Ma200
- 2.62
- Earnings Date
- Nov 23, 2026
- Pct From52w High
- -75.60%
- Pct From52w Low
- 23.58%